Physician profile
Aman Arora
NPI 1700091881
$1,916.95
in general payments reported to CMS, 2019-2025
19 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $200 · 2021: $118 · 2022: $228 · 2023: $383 · 2024: $427 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $714.34 | 2019-2025 | Lifevest |
| Abbvie INC. | $305.14 | 2021-2025 | Teflaro, Dalvance |
| Novartis Pharmaceuticals Corporation | $171.50 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $162.30 | 2019-2024 | Xarelto |
| Abbott Laboratories | $70.31 | 2024-2025 | Cardiomems |
| Astrazeneca Pharmaceuticals Lp | $69.77 | 2019-2022 | |
| Pfizer INC. | $56.88 | 2021-2025 | |
| Cvrx, INC. | $52.37 | 2024 | Barostim Neo System |
| Allergan, INC. | $48.89 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.30 | 2022 | |
| Kestra Medical Technology Services, INC. | $35.25 | 2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $32.52 | 2024 | Eliquis |
| Boston Scientific Corporation | $32.42 | 2025 | Watchman Access System |
| Smith+Nephew, INC. | $30.75 | 2023-2025 | Collagenase Santyl |
| Esperion Therapeutics, INC. | $24.62 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $21.11 | 2023 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $19.89 | 2019 | |
| Cook Medical LLC | $14.30 | 2024 | S~Curve |
| Tetraphase Pharmaceuticals, INC. | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aman Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.